Heartforce’s Afib detection algorithm was tested on a large database of 84k cases with an accuracy equivalent to current FDA approved algorithms. Afib detection will be deployed on future CardioClin and CardioPro products and will be ready for Health Canada and FDA submissions.
05
Jun 2023
Need to get in touch with the team? We’re all ears.
Contact us today.
This website (“Web Site”) is offered to you by HeartForce Medical Inc. (HeartForce), Vancouver, BC, Canada.
The following Terms of Use govern your access and use of this Web Site and its service. Also, specific terms and conditions may apply to specific content, data, materials, or information contained on or available through this Web Site (the “Content”) and to specific content, data, materials, or information you may upload, submit and/or publish to the Web Site (“User Content”) or transactions concluded through this Web Site.
The following Terms of Use govern your access and use of this Web Site and its service. Also, specific terms and conditions may apply to specific content, data, materials, or information contained on or available through this Web Site (the “Content”) and to specific content, data, materials, or information you may upload, submit and/or publish to the Web Site (“User Content”) or transactions concluded through this Web Site.